… COVID-19–induced respiratory failure. The physiology does not directly prove pulmonary
angiopathy, … of vascular abnormalities and pulmonary angiopathy in severe COVID-19. Future …

… Pulmonary vascular abnormalities such as vessel enlargement and regional mosaic …
COVID-19 pneumonia. Perfusion abnormalities are also frequently observed at DECT in COVID-19 …

… In situ pulmonary arterial thrombosis in COVID-19 is not visible on CTPA. However, the
presence of CT-measured right heart and pulmonary artery dilatation in COVID-19 is likely …

… thrombosis; PBV/PAenh is significantly reduced in COVID-19 pneumonia and has an … that
COVID-19 pulmonary angiopathy may reflect an acute feature of severe COVID-19 pneumonia…

… who were critically ill with COVID-19 (6). Third, the therapy from pulmonary embolism was
not … the treatment for pulmonary embolism in patients with COVID-19 should be different from …

… thrombosis and thromboembolism as a key feature of COVID-19… prospect of long-lasting
pulmonary fibrotic damage and plan for … of COVID-19 are not known, should pulmonary vascular …

… et al. estimated pulmonary embolism prevalence in COVID-19 … Pulmonary embolism in
COVID-19 patients seems to be … microvascular clot formation and angiopathy in lungs and other …

… supernatant cytokine levels in severe COVID-19 infection. First-… the pulmonary immune
environment during a fatal COVID-19 … was positive on all three pulmonary samples, and diffuse …

… among COVID-19 … pulmonary embolism. Other radiological vascular signs might solve this
confusion. This study investigated other indirect vascular angiopathy signs on CT pulmonary …

… Moreover, recent findings of pulmonary angiopathy in patients with severe COVID-19 highlight
the likely involvement of endotheliopathy contributing to the pulmonary perfusion defects, …